Trodelvy 2020 report
Trodelvy 2020 U.S. PROMOTIONAL AUDIT REPORT
Published July 2021 • 22 Pages
The 5 Key Questions Addressed by this Report:
- How many physicians were reached by Trodelvy through reportable promotional activity in 2020 and how does this compare to its peer set in the Breast Cancer market?
- How does Immunomedics’s depth of coverage vary within key specialties (e.g., Hematology/Oncology, Medical Oncology, and Internal Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians?
- How often are physicians receiving paid meals for Trodelvy throughout the year (e.g., monthly, quarterly, annually)?
- Who were the most frequent meal recipients and top paid speakers for Trodelvy in 2020?
Data Sources and Methodology:
- Over 400 paid interactions across 300 physicians made on behalf of Trodelvy were carefully examined to support our analysis. In addition, interaction data from 19 peer products (e.g. Enhertu, Femara, Halaven, Ibrance, Kadcyla, Kanjinti, Keytruda, Kisqali, Lynparza, Nerlynx, Ogivri, Perjeta, Phesgo, Piqray, Talzenna, Tecentriq, Trazimera, Tukysa, and Verzenio ) was leveraged to provide benchmarking and market insights.